-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $57

Benzinga·11/04/2026 16:13:03
RBC Capital analyst Leonid Timashev maintains Alkermes (NASDAQ:ALKS) with a Outperform and raises the price target from $56 to $57.